Staphylococcus aureus is an opportunistic pathogen which has become a serious clinical problem because of the emergence of strains that are resistant to a large number of antimicrobial compounds and consequently may be intransigent to chemotherapy (20) . Resistance to antiseptics and disinfectants in S. aureus isolates is typically due to the presence of any one of three determinants, designated qacA, qacB, and qacC, which vary in ability to confer resistance to a range of toxic organic cations (11, 15, 20) . qacA specifies resistance to intercalating dyes (such as ethidium bromide), quaternary ammonium compounds (such as cetrimide), and divalent cations (such as chlorhexidine). qacB, which is closely related to qacA (27) , characteristically differs from this determinant by conferring low-level or no resistance to divalent cations (15) , whereas qacC, which is genetically unrelated to qacA and gacB, mediates resistance to quaternary ammonium compounds and some dyes (15) .
The qac determinants confer resistance to structurally diverse compounds via export, driven by the proton motive force of the transmembrane electrochemical proton gradient (7, 15, 30) . Most active export systems deal with a single substrate or a small group of structurally related substrates, e.g., tetracycline extrusion is mediated by TetB in Escherichia coli (12) . In contrast, a number of multidrug export systems which can handle a range of structurally disparate substrates have been identified (13, 26, 28) . Examples of bacterial multidrug export systems include those encoded by bmr in Bacillus subtilis (25) , emrB in E. coli (16) , and the qac genes in S. aureus (15) .
The qacA (33, 40) , qacB (15, 27) , and qacC (14) genes have been cloned and expressed in E. coli, and their nucleotide sequences have been determined. The deduced products of the qacA and qacB genes have been predicted to be membrane proteins with 14 transmembrane segments (TMS) (27, 29, 33) and exhibit sequence similarity with import and export proteins of the major facilitator superfamily (6, 22, 29) . The qacC gene, which has also previously been called qacD (14) and is identical in sequence to the staphylococcal smr (7) and ebr (37) genes, codes for a much smaller membrane protein which is a member of a family of prokaryotic multidrug resistance proteins (7, 14, 28) . This family includes the proposed multidrug exporters Ebr from E. coli (24, 31) and QacE and its semifunctional derivative QacE⌬1 from integrons in gram-negative bacteria (28) . Members of this family typically contain four highly hydrophobic regions which may form alpha-helical TMS (7, 28 ) (see Fig. 1 ).
In this study, we have investigated the membrane topology of the QacC protein by genetic fusion, with alkaline phosphatase and ␤-galactosidase as reporters of subcellular localization (for a review, see reference 42). Mutagenesis and biochemical analyses were utilized to investigate the potential roles of specific residues within QacC in multidrug export.
MATERIALS AND METHODS
Bacterial strains and plasmids. S. aureus SK982 (19) and E. coli K-12 strains DH5␣ (endA hsdR17 supE44 thi-1 Ϫ recA1 gyrA96 relA1 80dlacZ⌬M15) (Bethesda Research Laboratories), CC118 [araD139 ⌬(ara leu)7697 ⌬lacX74 phoA⌬20 galE galK thi rspE rpoB argE recA1) (21) , and CJ236 [dut-1 ung-1 thi-1 relA1 pJC105 (Cm r )] (9) were employed in this study. The S. aureus plasmids used were pSK1 (qacA) (41), pSK41 (qacC) (14) , pSK89 (qacC) (14) , and pJE1 (qacC) (2, 3) . E. coli plasmid vectors pUC118 (45), pPHO7 (8), pSK4158 (this study), and pSU2718 (23) and qacC-encoding plasmids pSK503 and pSK530 (14) were utilized in this study.
General methods. The media used and the method for MIC determinations have been described previously (15, 18) . MIC tests were performed at least in triplicate.
DNA methodology. Standard molecular cloning techniques were performed as previously described (34) . Transposon mutagenesis with transposon TnphoA was performed as previously described (21) . PCRs were performed with Pfu DNA polymerase (Stratagene) according to the manufacturer's recommendations. Nucleotide sequences were determined by the procedure of Sanger et al. (35) , with a T7 DNA polymerase sequencing kit (Pharmacia) and specific oligonucleotides as sequencing primers.
Ethidium transport assays. Ethidium accumulation and efflux were assayed indirectly by fluorimetric assay as previously described (24, 41) . All fluorimetric assays were performed in at least triplicate. N-Ethylmaleimide (NEM) (1 mM) and carbonyl cyanide m-chlorophenylhydrazone (5 M) were added as previously described (4, 41) .
Enzymatic assays. Alkaline phosphatase activities were determined as previously described (1) with p-nitrophenyl phosphate. ␤-Galactosidase activities were estimated by scoring the ability of colonies to cleave the chromogenic substrate 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside as described previously (38, 39) .
Western (immunoblot) analysis. Proteins from whole-cell extracts were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as previously described (10) . Western transfer of proteins to a nitrocellulose membrane was performed by using a Bio-Rad TransBlot semidry transfer cell according to the manufacturer's recommendations. Alkaline phosphatase fusion proteins were detected immunologically with rabbit anti-PhoA immunoglobulin G (5 Prime 3 3 Prime, Inc.) as previously described (21) .
Site-directed mutagenesis. Site-specific oligonucleotide-directed mutagenesis of qacC was undertaken as described by Kunkel et al. (9) , with a single-stranded DNA template. The following oligonucleotide primers were employed in mutagenesis: C42X (ACAATAATTTCATTTGGAATTZXXTTCTATTTTTTAA GTAAAACA), P32G (CAAAATTTATAGGATCCTTAGGAAC), P32A (CAA AATTTATAGCATCCTTAGGAAC), Y59W (CTAAATATAACTTGGGCAA CTTGGGC), Y59S (CTAAATATAACAGTGGCAACTTGGGC), W62F (CT TATGCAACTTTCGCGGGACTAGG), and W62Y (CTTATGCAACTTAC GCGGGACTAGG). The introduced codon changes are indicated in boldface; X represents any base, and Z represents any base except T. Oligonucleotides were synthesized on a Beckman Oligo 1000 DNA synthesiser.
RESULTS
Construction of qacC-phoA and qacC-lacZ␣ fusions. The proposed four-TMS topological model of the QacC polypeptide (14, 28) (Fig. 1) was investigated by constructing a series of gene fusions between qacC and the alkaline phosphatase gene (phoA) without its signal peptide sequence by a combination of in vivo and in vitro techniques. This approach is based on the observation that alkaline phosphatase is highly active when exported across the cell membrane but exhibits low-level activity in the cytoplasm. Hence, in-frame fusions of the alkaline phosphatase gene to a target membrane protein gene can differentiate between regions that code for cytosolic domains and those that code for periplasmic domains of the membrane protein on the basis of the observed levels of alkaline phosphatase activity (42) . The qacC-encoded multidrug export system functions in E. coli as well as in S. aureus, conferring similar resistance spectra in both organisms (15) . Hence, the QacC polypeptide presumably maintains the same orientation and topology in the membrane of each of these organisms. Therefore, for ease of analysis, these qacC-phoA chimeras were expressed and analyzed in E. coli. Similarly, other membrane proteins from a wide variety of organisms have been studied by expression of phoA fusions in E. coli (for examples, see references 43, 46, and 48) .
Initially, qacC-phoA gene fusions were constructed by in vivo transposition of transposon TnphoA (21) into qacC-containing plasmids pSK503 and pSK530. However, only three unique in-frame qacC-phoA fusions were isolated by this procedure, and nucleotide sequencing of these constructs with a phoAspecific oligonucleotide as a primer revealed that they encoded hybrid QacC-PhoA proteins that contained residues 1 to 14 (pSK650), 1 to 25 (pSK649), and 1 to 37 (pSK651) of QacC (Table 1 and Fig. 1 ). In order to clarify the topology of QacC, additional qacC-phoA fusions were constructed in vitro by cloning specific PCR products from qacC into the phoA vector pSK4158. Cm r vector pSK4158, which contains the phoA gene preceded by a unique multiple cloning site and carries a P15A origin of replication, was constructed as shown in Fig. 2 . Plasmid pPHO7, which contains the phoA gene flanked by two essentially identical multiple cloning sites (8) , was digested with restriction enzyme XhoI, blunt ended by filling in the ends with the Klenow fragment of DNA polymerase I, and digested with HindIII. The resulting 2.6-kb HindIII blunt fragment that contained the phoA gene was gel purified and cloned into the HindIII-SmaI sites of Cm r vector pSU2718 to yield vector pSK4158.
Specific PCR fragments amplified from template DNA (pSK503) that contained qacC were digested with BamHI and cloned into the multiple cloning site of pSK4158 to generate qacC-phoA hybrids that encoded residues 1 to 55 (pSK4174), 1 to 76 (pSK4172), and 1 to 107 (pSK4173) of the QacC protein (Table 1 and Fig. 1 ). The DNA sequence at the fusion joint of each of these constructs was confirmed by nucleotide sequencing. The locations of the PhoA fusions in these hybrid QacCPhoA proteins are shown in Fig. 1 (triangles). As can be seen from this figure, these hybrid proteins represent fusions to putative hydrophilic loops C1, P1, and P2, putative intramembranous regions TMS I and TMS II, and the C terminus (COOH) of QacC. Table 1 ). The locations of residues within QacC which were targeted by site-directed mutagenesis in this study are highlighted. To obtain information that was complementary to that provided by alkaline phosphatase studies, fusions between qacC and an alternative reporter gene, lacZ, were also constructed. The LacZ␣ peptide had previously been used as a reporter of subcellular localization (38, 39) , providing complementary information to that from alkaline phosphatase studies, with high ␤-galactosidase activity indicative of a cytoplasmic location. Specific qacC PCR fragments were digested with BamHI and cloned into the multiple cloning site of pUC118 to generate qacC-lacZ chimeras pSK4211 and pSK4212, which correspond to fusions between the C1 and P2 regions of QacC and the ␣ fragment of ␤-galactosidase ( Fig. 1 [squares] ), at positions that were identical to the qacC-phoA fusions encoded by pSK4174 and pSK4172, respectively. Repeated attempts to generate a qacC-lacZ hybrid that corresponded to a fusion between the COOH terminus of QacC and the LacZ␣ peptide by this ap- Fig. 1 ) and ␤-galactosidase (Fig. 1 ) activities of cells that harbored various qacC-phoA or qacC-lacZ constructs were assayed. Cells which contained qacC-phoA fusions that corresponded to the projected periplasmic regions, P1 and P2, exhibited high-level alkaline phosphatase activities (261 to 288 U), whereas the qacC-phoA fusion which codes for PhoA fused to the predicted cytoplasmic region C1 of QacC conferred low-level alkaline phosphatase activities (33 U). The two qacC-lacZ hybrids that corresponded to fusions to C1 and P2 of QacC conferred reciprocal enzymatic activities compared with those of the equivalent qacC-phoA hybrids (Fig. 1) . Cells that harbored qacC-phoA fusions that corresponded to the proposed intramembrane regions, TMS I and TMS II, of the QacC polypeptide displayed intermediate levels of alkaline phosphatase activity (155 to 161 U), as did cells that contained pSK4173, which encodes a hybrid protein that consists of the C terminus of QacC fused to PhoA (170 U). With the exception of pSK4173, the enzymatic activities conferred by qacC-phoA and qacC-lacZ fusions were consistent with the proposed topological model of QacC (Fig. 1) . The possible reasons for the high-level activity of pSK4173 are considered below.
To identify the hybrid proteins that are encoded by these qacC-phoA constructs, whole-cell extracts were separated by SDS-PAGE, transferred to nitrocellulose, and analyzed by Western blotting with anti-PhoA immunoglobulin G. Hybrid proteins of the predicted sizes, encoded by each of these constructs, were readily detected by immunostaining (Fig. 3) ; in each case, a smaller faint band that corresponded in size to the PhoA moiety (ϳ47 kDa) was also observed. In some cases, additional products were observed; e.g., in the case of the C-terminal QacC-PhoA fusion encoded by pSK4173, a product of ϳ49 kDa, which may be responsible for the observed alkaline phosphatase activity, was also observed (Fig. 3, lane 2) . These additional products were most probably derived from proteolysis of hybrid proteins, as previously observed with other alkaline phosphatase fusion proteins (43) .
The multidrug resistance activities of the various gene fusions were assessed by MIC analysis and ethidium transport assays. None of the plasmids that carried qacC-phoA or qacClacZ chimeras conferred resistance to ethidium bromide or quaternary ammonium compounds, with the exception of pSK4173, which codes for a hybrid QacC-PhoA fusion that contains all 107 amino acids of QacC. pSK4173 conveyed resistance to a range of qacC substrates at levels that were approximately 50 to 75% of those of wild-type qacC (data not shown). Similarly, proton motive force-dependent ethidium efflux was observed in E. coli cells that contained pSK4173 at rates that were approximately 50% of the rate of qacC-mediated export (data not shown). This suggests that the hybrid protein encoded by pSK4173 is properly localized in the membrane.
Effect of NEM on qacC-encoded ethidium efflux. NEM is a membrane-permeable thiol reagent which covalently bonds to the sulfhydryl groups of cysteine residues (44) . The roles of cysteine residues in various transport systems, such as the E. coli lactose permease LacY (4) and glucose-6-phosphate transporter UhpT (47), have been evaluated by using sulfhydrylspecific reagents and subsequent site-directed mutagenesis. An analogous approach was utilized to examine the role of the sole QacC cysteine residue, Cys-42, in ethidium efflux.
The addition of 1 mM NEM was observed to inhibit ethidium export in S. aureus cells that harbored qacC plasmid pSK89 (Fig. 4a) , pSK41 (data not shown), or pJE1 (data not shown). Similarly, ethidium accumulation in qacC-encoding strains was increased following NEM treatment (Fig. 4b) . As controls, the effects of 1 mM NEM on ethidium transport in the background S. aureus strain and in cells that expressed qacA, whose product does not contain any cysteine residues, were examined. NEM was found to have no detectable effect on ethidium accumulation and efflux in either S. aureus SK982 or cells that expressed the qacA encoded on pSK1 ( Fig. 4a and  b) . These data suggest that NEM does not exert a generalized effect on ethidium transport or on proton motive force generation in S. aureus under the experimental conditions used but, instead, specifically inhibits qacC-encoded ethidium export.
A number of NEM-sensitive transport proteins have been shown to be partially protected from NEM inhibition by their appropriate substrates, such as the lactose permease LacY (4). In other instances (e.g., human erythrocyte D-glucose transporter), the transport substrate accelerates the rate of NEM inhibition (32) . The effect of excess substrate on NEM inhibition of qacC-encoded ethidium export was examined indirectly by assaying the relative rates of ethidium accumulation by cells that contained pSK89 in the presence of a 10-fold excess of ethidium bromide (50 M). Under these conditions, the addition of 1 mM NEM induced only a slight increase in the rate of ethidium accumulation (Fig. 4c) , indicating that excess substrate may partially protect the qacC-encoded ethidium export system from the inhibitory effects of NEM. As a control, the addition of an alternative inhibitor, such as the protonophore carbonyl cyanide m-chlorophenylhydrazone, resulted in a rapid increase in ethidium accumulation (data not shown).
Generation of qacC (Cys-42) mutants. The possible role of FIG. 3 . Western hybridization analysis of products from cells that expressed qacC-phoA fusions with anti-PhoA antisera. Whole-cell extracts were separated by electrophoresis on 10% polyacrylamide gels, transferred to nitrocellulose, and immunostained (see Materials and Methods). The results with extracts from E. coli CC118 cells that harbored the indicated plasmid are shown in the following lanes (with the putative subcellular location of the fusion junction within the hybrid protein encoded by each of these constructs indicated in parentheses): 1, no plasmid; 2, pSK4173 (COOH); 3, pSK4172 (P2); 4, pSK4174 (C1); 5, pSK651 (TMS II); 6, pSK650 (TMS I); 7, pSK649 (P1). In lanes 2 through 7, the prominent upper band corresponds in size to that expected of hybrid QacCPhoA proteins. Additionally, faint bands are evident in lanes 2 through 7 (most clearly visible in lanes 4 and 5); they correspond in size to the alkaline phosphatase moiety, PhoA, and are indicated by an arrow on the right. The migrations and sizes (in kilodaltons) of coelectrophoresed standard proteins are also shown on the right.
Cys-42 in the QacC polypeptide was investigated by utilizing site-directed mutagenesis to construct a series of qacC mutants with an altered cysteine codon at this position. The qacCencoding plasmid pSK89 was linearized by digestion with PstI and cloned into the PstI site of vector pUC118 to generate pSK660. By using single-stranded DNA derived from phagemid pSK660 as a template, qacC mutants were constructed by the method of Kunkel et al. (9) . Changes were introduced by using the degenerate oligonucleotide C42X, in which the cysteine codon (TGT) had been replaced by ZXX (see Materials and Methods). Potential mutants were screened phenotypically and by nucleotide sequencing, and 12 mutants which contained different single amino acid alterations in place of Cys-42 in QacC were identified.
In each case, completion of the nucleotide sequences on both strands of the mutant qacC genes verified that no spurious mutations had been introduced. The relative resistance specificities to organic cations conferred by each of these mutants were investigated by MIC analyses ( Table 2 ). Strains that harbored the qacC cysteine-to-isoleucine at amino acid 42 (C42I), C42L, C42V, C42P, C42D, C42E, C42K, or C42R mutant were sensitive to all of the compounds tested. All of these mutations result in radical substitutions, such as the introduction of a charged residue (D, E, K, or R), an alphahelix-breaking residue (P), or a residue with a large side chain volume (V, I, or L). In contrast, the qacC C42T mutant, whose product contains a conservative cysteine-to-threonine substitution, retained full activity, conferring resistance to both quaternary ammonium compounds and intercalating dyes. The remaining qacC mutants, C42A, C42G, and C42S, conveyed resistance to quaternary ammonium compounds but conferred only reduced or no resistance to intercalating dyes, such as ethidium bromide and crystal violet, compared with that of qacC.
In support of the susceptibility data, fluorimetric transport assays of ethidium export indicated that the qacC C42T mutant conferred a rate of ethidium efflux that was similar to that of wild-type qacC, the C42A and C42G mutants conveyed reduced rates of ethidium efflux, and no detectable ethidium efflux was observed with the remaining mutants (Fig. 5 and   FIG. 4 . Effects of the sulfhydryl reagent NEM on ethidium export and accumulation by qacC-encoding cells. (a) Ethidium export in S. aureus SK982 cells that harbored the following plasmids was examined under the conditions noted: --, no plasmids and addition or no addition of 1 mM NEM; ----, pSK89 (qacC) with no addition; --, pSK89 (qacC) with addition of 1 mM NEM; ---, pSK1 (qacA) with no addition of 1 mM NEM. (b) Ethidium accumulation in S. aureus SK982 cells that harbored the indicated plasmid. Ethidium bromide (5 M) was added at the time indicated by arrow A; in the instances indicated, 1 mM NEM was added at the time indicated by arrow B. --, no plasmids and addition or no addition of 1 mM NEM; ----, pSK89 (qacC) with no addition; --, pSK89 (qacC) with addition of 1 mM NEM; ---, pSK1 (qacA) with no addition of 1 mM NEM. (c) Ethidium accumulation, in the presence of excess ethidium, in S. aureus SK982 cells that harbored the indicated plasmid was examined. Ethidium bromide (50 M) was added at the time indicated by arrow A; in the instances indicated, 1 mM NEM was added at the time indicated by arrow B. ----, pSK89 (qacC) with no addition; --, pSK89 (qacC) with addition of 1 mM NEM; ---, pSKl (qacA) with addition or no addition of 1 mM NEM. data not shown). To confirm that the observed NEM inhibition of qacC-encoded ethidium export was due to interaction between NEM and the sulfhydryl group of Cys-42, the effect of NEM on ethidium export conferred by the qacC C42T mutant was assessed. The addition of 1 mM NEM had no detectable effect on the rate of ethidium export in cells that harbored pSK687, which encodes the qacC C42T mutant (data not shown).
Site-directed mutagenesis of residues located within conserved motifs. QacC shares four highly conserved regions with other related proteins, such as QacE (28) . In particular, it has been proposed that the conserved motifs which are located in TMS II and III of these proteins may be involved in substrate recognition (28) . To investigate the potential role of these two regions in QacC-mediated drug export, site-directed mutagenesis of qacC was undertaken to target the residues, Pro-31, Tyr-59, and Trp-62, which are absolutely conserved among the members of this family of proteins. By utilizing the mutagenic oligonucleotides listed in Materials and Methods, two substitutions were introduced for each of these three residues within QacC ( Table 2) .
MIC analyses (Table 2 ) and transport assays (data not shown) indicated that the qacC Pro-31 mutants (P31G and P31A) conferred a phenotype that was similar to that of the qacC Cys-42 mutants (C42G and C42A), viz., reduced resistance to ethidium bromide and crystal violet and high-level resistance to quaternary ammonium compounds (Table 2 ). In contrast, the Tyr-59 mutants (Y59W and Y59S) and Trp-62 mutants (W62Y and W62F) displayed negligible levels of resistance against all of the compounds tested (Table 2) , suggesting that these residues play a critical role in the structure or function of the QacC polypeptide.
DISCUSSION
A series of qacC-phoA and qacC-lacZ gene fusions were constructed and analyzed to test the proposed four-TMS topology of QacC. The enzymatic activities conferred by these constructs were consistent with the proposed topology and orientation of TMS I through III of QacC (Fig. 1) , with the N terminus of QacC located cytoplasmically. However, the location of the C terminus of QacC was not positively assigned. Cells that harbored pSK4173, which encodes a hybrid protein that consists of PhoA fused to the C terminus of QacC, exhibited alkaline phosphatase activities that were approximately 60% of those of cells that encode hybrid proteins with PhoA fused to proposed periplasmic regions of QacC (Table 1 and Fig. 1) .
Immunostaining of extracts from cells that carried pSK4173 with anti-PhoA antisera identified two prominent products (Fig. 3, lane 2) . One of these products corresponded with the expected size of the chimeric protein encoded by pSK4173, and a smaller product migrated to approximately 49 kDa. The smaller product is presumably derived from proteolysis of the QacC-PhoA fusion protein, as no potential restart codon exists at an appropriate position within qacC. In this case, it may represent a polypeptide that consists of the entire PhoA moiety (47 kDa) fused to the C-terminal 20 to 30 amino acids of QacC. This product may be largely or entirely responsible for the observed alkaline phosphatase activities in cells that harbor pSK4173, as the hydrophobic C-terminal 20 to 30 amino acids of QacC may act as a signal sequence to promote translocation of the PhoA moiety across the membrane. On this basis, the full-length chimeric protein encoded by pSK4173 may exhibit only low-level activity in accord with its predicted cytoplasmic location. Further studies are required to clarify this possibility and confirm the location of the C terminus of QacC.
qacC-encoded ethidium export was demonstrated to be sensitive to the effects of the sulfhydryl reagent NEM, and the presence of excess ethidium appeared to partially protect against such NEM inhibition. Site-directed mutagenesis with a degenerate oligonucleotide was employed to generate a range of qacC (Cys-42) mutants, whose phenotypes were subsequently analyzed. The replacement of cysteine with threonine (which is similar in side chain volume and H-bonding ability) resulted in a mutant whose phenotype was indistinguishable from that of wild-type qacC, suggesting that Cys-42 does not play a direct role in QacC-mediated drug export or in the formation of disulfide bonds. However, other substitutions of residues with similar side chain volumes (Ala, Gly, and Ser) at this location specifically affected the ability to confer resistance to compounds such as ethidium and crystal violet ( Table 2 ). The ability of these mutations to modulate the activity and substrate specificity of the qacC-encoded multidrug export system implies that these substitutions affect regions of the protein that are involved in substrate recognition or binding. The notion that this residue may be located near a region that is involved in substrate binding is supported by indirect evidence that suggests that partial protection from NEM inhibition of qacC-encoded ethidium export is provided by excess ethidium bromide (Fig. 4c) .
The roles of the conserved QacC residues Pro-31, Tyr-59, and Trp-62 were also investigated by site-directed mutagenesis. Replacement of Pro with either Gly or Ala, both of which have similar side chain volumes, led to a reduction in resistance to ethidium and crystal violet in a manner that was analogous to that observed with qacC C42A, C42G, and C42S mutants, suggesting that this residue is also located near a region that is involved in determining substrate specificity in QacC. As these mutations affected the levels of resistance and export conferred by qacC to a specific class of substrates, there may be differences in the requirements for binding or export of particular substrates by QacC. A similar situation has been observed for the mammalian multidrug resistance P-glycoprotein, in which a number of point mutations have been observed to affect transport of particular classes of substrates (5, 17) . There may be separate but potentially overlapping binding sites in these proteins for different classes of substrates.
Substitutions at Tyr-59 and Trp-62 abolished or greatly reduced the levels of resistance to all of the compounds tested, suggesting that these residues play a crucial structural or func- FIG. 5 . Fluorimetric assays of ethidium export conferred by qacC and selected qacC (Cys-42) mutants. E. coli DH5␣ cells that harbored plasmids that encode the following qacC variants were loaded with ethidium bromide, and ethidium export was energized by the addition of 50 mM sodium formate at time zero. --, negative control (DH5␣ alone); ----, wild-type qacC; ---, qacC C42G; --, qacC C42S. In this experiment, ethidium export in E. coli DH5␣ cells that expressed the qacC C42T mutant was indistinguishable from that observed for wild-type qacC.
tional role in QacC. Speculatively, the aromatic nature of these Tyr and Trp residues and their predicted locations on approximately the same face of the alpha-helix of TMS III of QacC (Fig. 1) pose the possibility that these residues interact with the hydrophobic regions of substrates of QacC, such as ethidium. Further biochemical characterization of the Tyr-59 and Trp-62 mutants may clarify whether these residues play a role in substrate binding.
Previous studies have shown that the qacC gene encodes a product involved in mediating multidrug export but have not established that the QacC protein acts as a multidrug exporter in its own right (7, 14, 15, 28, 36) . The identification in this study of a number of specific point mutations in QacC which affect the substrate specificity of multidrug export provides support for the notion that QacC does function as a multidrug exporter.
